Vittoria Lopez News Today : Breaking News, Live Updates & Top Stories | Vimarsana

 E-Mail IMAGE: with one of the newly developed inhibitors in the active centre. The individual domains of the protein are shown in different colours, the inhibitor in pink. view more  Credit: © V. Namasivayam/Pharmazeutisches Institut/Uni Bonn A research team of pharmacists at the University of Bonn has discovered two families of active substances that can block the replication of the SARS-CoV-2 coronavirus. The drug candidates are able to switch off the the key enzyme of the virus, the so-called main protease. The study is based on laboratory experiments. Extensive clinical trials are still required for their further development as therapeutic drugs. The results have now been published in the journal

Nordrhein westfalenVigneshwaran namasivayamKatharina sylvesterDominik thimmGhazl al hamwiChristin vielmuthJochen bodemVittoria lopezSalahuddin mirzaThanigaimalai pillaiyarCarina lemkeAngewandte chemieRobin gedscholdMaria zyulinaPhuong vuJulian breidenbach